Berlin, Germany

Adriano Taddeo

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Beutsches Rheuma-Forschungszentrum Berlin (Drfz). Active years: 2018.


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Adriano Taddeo

Introduction

Adriano Taddeo is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biomedical research, particularly in the development of compositions and methods related to plasma cell antibodies. His innovative work has led to the filing of a patent that showcases his expertise and creativity.

Latest Patents

Adriano Taddeo holds a patent for a composition that comprises an anchor region capable of binding to a plasma cell, along with a binding region associated with the anchor region. This binding region is designed to bind a specific plasma cell antibody. His patent represents a significant advancement in the understanding and manipulation of plasma cells, which are crucial in the immune response.

Career Highlights

Throughout his career, Taddeo has worked with esteemed institutions such as the Deutsches Rheuma-Forschungszentrum Berlin. His experience in these organizations has allowed him to collaborate with leading researchers in the field, further enhancing his contributions to biomedical science.

Collaborations

Adriano Taddeo has collaborated with notable colleagues, including Andreas Radbruch and Falk Hiepe. These partnerships have fostered a rich environment for innovation and have led to advancements in their shared research interests.

Conclusion

Adriano Taddeo's work exemplifies the spirit of innovation in the biomedical field. His patent and collaborations highlight his commitment to advancing scientific knowledge and improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…